Sign in

Immunome Inc.

Income Statement - Immunome Inc. (IMNM)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.22 0.31 0.12 0.04 0.03 0.01 0.01 0.01
Operating income -0.21 -0.31 -0.11 -0.04 -0.03 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.01 0.00 0.00 0.00 -0.01 0.00 0.00
Income before tax -0.21 -0.29 -0.11 -0.04 -0.02 -0.02 -0.01 -0.01
Income tax expense -0.29 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.21 -0.29 -0.11 -0.04 -0.02 -0.02 -0.01 -0.01
Show Quarterly Income Statement

Income Statement - Immunome Inc. (IMNM)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 -0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.07 0.01 0.05 0.05 0.09 0.05 0.04 0.13 0.10 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating income -0.06 -0.07 -0.06 -0.05 -0.04 -0.08 -0.05 -0.04 -0.13 -0.09 0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.07 -0.06 -0.04 -0.04 -0.08 -0.05 -0.04 -0.13 -0.09 0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.05 -0.07 -0.06 -0.04 -0.04 -0.08 -0.05 -0.04 -0.13 -0.09 0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
4 days ago

Balance Sheet - Immunome Inc. (IMNM)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.65 0.22 0.14 0.02 0.05 0.04 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other current assets 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Total current assets 0.66 0.22 0.14 0.02 0.06 0.04 0.00 0.00
Total non-current assets + 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.68 0.24 0.15 0.02 0.06 0.04 0.01 0.00
Total current liabilities + 0.04 0.05 0.02 0.01 0.01 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.01 0.00 0.00 0.00 0.04 0.03
Total liabilities 0.05 0.06 0.03 0.01 0.01 0.00 0.04 0.03
Total stockholders' equity + 0.63 0.18 0.12 0.02 0.05 0.04 -0.04 -0.03
Common shares outstanding 87 59 20 12 12 10 6 1
Show Quarterly Balance Sheet

Balance Sheet - Immunome Inc. (IMNM)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total cash and short-term investments + 0.58 0.65 0.27 0.27 0.32 0.22 0.24 0.28 0.31 0.14 0.09 0.04 0.04 0.02 0.03 0.03 0.04 0.05 0.06 0.06 0.04 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.59 0.66 0.28 0.28 0.32 0.22 0.24 0.28 0.31 0.14 0.09 0.04 0.05 0.02 0.03 0.04 0.05 0.06 0.06 0.06 0.04 0.04 0.01 0.01 0.00 0.00 0.00 0.00
Total non-current assets + 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.62 0.68 0.30 0.30 0.34 0.24 0.26 0.30 0.32 0.15 0.09 0.04 0.05 0.02 0.03 0.04 0.05 0.06 0.06 0.06 0.04 0.04 0.01 0.01 0.01
Total current liabilities + 0.03 0.04 0.03 0.02 0.03 0.05 0.04 0.04 0.03 0.02 0.02 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.06 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.04
Total liabilities 0.03 0.05 0.04 0.03 0.04 0.06 0.04 0.04 0.03 0.03 0.09 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.06 0.00 0.04
Total stockholders' equity + 0.59 0.63 0.26 0.27 0.31 0.18 0.21 0.25 0.29 0.12 0.01 0.01 0.01 0.02 0.02 0.03 0.04 0.05 0.05 0.06 0.04 0.04 -0.05 0.01 0.00 -0.04 0.00
Common shares outstanding 113 87 88 87 79 63 60 60 10 22 12 12 12 12 12 12 12 12 12 11 11 10 10 9 6 6 6 1 1
4 days ago

Cash Flow - Immunome Inc. (IMNM)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.19 -0.11 -0.01 -0.03 -0.02 -0.01 -0.01 -0.01
Cash flow from investing + 0.06 -0.09 -0.03 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.64 0.24 0.12 0.00 0.03 0.05 0.01 0.00
Change in cash 0.51 0.04 0.08 -0.03 0.01 0.04 0.00 -0.01
Show Quarterly Cash Flow

Cash Flow - Immunome Inc. (IMNM)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Operating cash flow + -0.06 -0.05 -0.04 -0.05 -0.05 -0.04 -0.03 -0.02 -0.01 -0.02 -0.01 -0.01 0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + -0.01 0.00 0.12 -0.06 0.01 0.01 0.02 -0.08 -0.04 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.43 0.05 0.00 0.16 0.02 0.00 0.00 0.22 0.06 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.04 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Change in cash -0.07 0.38 0.13 -0.11 0.11 -0.01 -0.01 -0.10 0.17 0.01 0.05 -0.01 0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.02 0.00 0.03 0.00 0.01 0.00 0.00 0.00 0.00 0.00
4 days ago

Immunome Inc. (IMNM) - Shares Outstanding Diluted

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Net Income

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Stock Based Compensation

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Cashflow From Investment

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago

Immunome Inc. (IMNM) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago